Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_C6,7 | Lung | Primary cancer | 2,958 | Other | 27.1% | 0.47 | 0.88 |
| NSCLC_38242124__IMC__175_C6,8 | Lung | Primary cancer | 3,105 | Tumor/Malignant | 80.2% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__175_C6,9 | Lung | Primary cancer | 2,279 | Tumor/Malignant | 34.9% | 0.96 | 0.18 |
| NSCLC_38242124__IMC__175_C7,1 | Lung | Primary cancer | 3,158 | Tumor/Malignant | 41.9% | 0.94 | 0.24 |
| NSCLC_38242124__IMC__175_C7,10 | Lung | Primary cancer | 2,719 | Tumor/Malignant | 42.4% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__175_C7,11 | Lung | Primary cancer | 3,325 | Tumor/Malignant | 34.6% | 0.57 | 0.81 |
| NSCLC_38242124__IMC__175_C7,12 | Lung | Primary cancer | 3,230 | Tumor/Malignant | 66.3% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__175_C7,13 | Lung | Primary cancer | 3,467 | Tumor/Malignant | 32.3% | 0.48 | 0.79 |
| NSCLC_38242124__IMC__175_C7,14 | Lung | Primary cancer | 1,598 | Stromal | 44.8% | 0.99 | 0.09 |
| NSCLC_38242124__IMC__175_C7,15 | Lung | Primary cancer | 2,553 | Tumor/Malignant | 28.7% | 0.43 | 0.89 |
| NSCLC_38242124__IMC__175_C7,16 | Lung | Primary cancer | 5,544 | Immune | 78.1% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__175_C7,2 | Lung | Primary cancer | 3,873 | Tumor/Malignant | 66.8% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__175_C7,3 | Lung | Primary cancer | 2,937 | Tumor/Malignant | 57.3% | 0.92 | 0.27 |
| NSCLC_38242124__IMC__175_C7,4 | Lung | Primary cancer | 2,526 | Tumor/Malignant | 57.6% | 0.93 | 0.24 |
| NSCLC_38242124__IMC__175_C7,5 | Lung | Primary cancer | 2,528 | Stromal | 32.7% | 0.90 | 0.33 |
| NSCLC_38242124__IMC__175_C7,6 | Lung | Primary cancer | 2,883 | Tumor/Malignant | 73.8% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__175_C7,7 | Lung | Primary cancer | 3,570 | Tumor/Malignant | 34.8% | 0.93 | 0.25 |
| NSCLC_38242124__IMC__175_C7,8 | Lung | Primary cancer | 3,179 | Tumor/Malignant | 55.7% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__175_C7,9 | Lung | Primary cancer | 3,931 | Stromal | 28.8% | 0.36 | 1.02 |
| NSCLC_38242124__IMC__175_C8,1 | Lung | Primary cancer | 1,215 | Tumor/Malignant | 39.3% | 0.90 | 0.36 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_C6,7 | Lung | Primary cancer | 2,958 | Myeloid | 25.2% | 0.79 | 0.51 |
| NSCLC_38242124__IMC__175_C6,8 | Lung | Primary cancer | 3,105 | Tumor/Malignant | 71.7% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_C6,9 | Lung | Primary cancer | 2,279 | Tumor/Malignant | 35.5% | 0.96 | 0.19 |
| NSCLC_38242124__IMC__175_C7,1 | Lung | Primary cancer | 3,158 | Tumor/Malignant | 38.8% | 0.95 | 0.20 |
| NSCLC_38242124__IMC__175_C7,10 | Lung | Primary cancer | 2,719 | Tumor/Malignant | 42.7% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__175_C7,11 | Lung | Primary cancer | 3,325 | Tumor/Malignant | 26.6% | 0.89 | 0.37 |
| NSCLC_38242124__IMC__175_C7,12 | Lung | Primary cancer | 3,230 | Tumor/Malignant | 56.8% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_C7,13 | Lung | Primary cancer | 3,467 | Tumor/Malignant | 29.4% | 0.96 | 0.19 |
| NSCLC_38242124__IMC__175_C7,14 | Lung | Primary cancer | 1,598 | Stromal | 43.5% | 0.99 | 0.08 |
| NSCLC_38242124__IMC__175_C7,15 | Lung | Primary cancer | 2,553 | Stromal | 25.1% | 0.58 | 0.91 |
| NSCLC_38242124__IMC__175_C7,16 | Lung | Primary cancer | 5,544 | Lymphoid | 74.3% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__175_C7,2 | Lung | Primary cancer | 3,873 | Tumor/Malignant | 63.3% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__175_C7,3 | Lung | Primary cancer | 2,937 | Tumor/Malignant | 40.7% | 0.97 | 0.15 |
| NSCLC_38242124__IMC__175_C7,4 | Lung | Primary cancer | 2,526 | Tumor/Malignant | 35.6% | 0.99 | 0.10 |
| NSCLC_38242124__IMC__175_C7,5 | Lung | Primary cancer | 2,528 | Stromal | 29.1% | 0.91 | 0.29 |
| NSCLC_38242124__IMC__175_C7,6 | Lung | Primary cancer | 2,883 | Tumor/Malignant | 71.8% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__175_C7,7 | Lung | Primary cancer | 3,570 | Tumor/Malignant | 41.3% | 0.69 | 0.64 |
| NSCLC_38242124__IMC__175_C7,8 | Lung | Primary cancer | 3,179 | Tumor/Malignant | 41.8% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__175_C7,9 | Lung | Primary cancer | 3,931 | Stromal | 26.3% | 0.38 | 1.11 |
| NSCLC_38242124__IMC__175_C8,1 | Lung | Primary cancer | 1,215 | Tumor/Malignant | 32.7% | 0.92 | 0.28 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_C6,7 | Lung | Primary cancer | 2,958 | Granulocyte | 31.0% | 0.38 | 0.91 |
| NSCLC_38242124__IMC__175_C6,8 | Lung | Primary cancer | 3,105 | Tumor/Malignant cell | 80.1% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__175_C6,9 | Lung | Primary cancer | 2,279 | Tumor/Malignant cell | 42.1% | 0.93 | 0.26 |
| NSCLC_38242124__IMC__175_C7,1 | Lung | Primary cancer | 3,158 | Tumor/Malignant cell | 48.2% | 0.92 | 0.30 |
| NSCLC_38242124__IMC__175_C7,10 | Lung | Primary cancer | 2,719 | Tumor/Malignant cell | 47.8% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__175_C7,11 | Lung | Primary cancer | 3,325 | Tumor/Malignant cell | 45.3% | 0.82 | 0.52 |
| NSCLC_38242124__IMC__175_C7,12 | Lung | Primary cancer | 3,230 | Tumor/Malignant cell | 67.1% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__175_C7,13 | Lung | Primary cancer | 3,467 | Tumor/Malignant cell | 39.6% | 0.91 | 0.33 |
| NSCLC_38242124__IMC__175_C7,14 | Lung | Primary cancer | 1,598 | Fibroblast | 44.2% | 0.98 | 0.12 |
| NSCLC_38242124__IMC__175_C7,15 | Lung | Primary cancer | 2,553 | Fibroblast | 28.2% | 0.75 | 0.68 |
| NSCLC_38242124__IMC__175_C7,16 | Lung | Primary cancer | 5,544 | B cell | 70.0% | 0.92 | 0.21 |
| NSCLC_38242124__IMC__175_C7,2 | Lung | Primary cancer | 3,873 | Tumor/Malignant cell | 66.8% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__175_C7,3 | Lung | Primary cancer | 2,937 | Tumor/Malignant cell | 57.8% | 0.92 | 0.29 |
| NSCLC_38242124__IMC__175_C7,4 | Lung | Primary cancer | 2,526 | Tumor/Malignant cell | 57.3% | 0.92 | 0.24 |
| NSCLC_38242124__IMC__175_C7,5 | Lung | Primary cancer | 2,528 | Fibroblast | 34.8% | 0.76 | 0.58 |
| NSCLC_38242124__IMC__175_C7,6 | Lung | Primary cancer | 2,883 | Tumor/Malignant cell | 74.6% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__175_C7,7 | Lung | Primary cancer | 3,570 | Tumor/Malignant cell | 45.1% | 0.89 | 0.35 |
| NSCLC_38242124__IMC__175_C7,8 | Lung | Primary cancer | 3,179 | Tumor/Malignant cell | 56.1% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__175_C7,9 | Lung | Primary cancer | 3,931 | Fibroblast | 25.3% | 0.70 | 0.75 |
| NSCLC_38242124__IMC__175_C8,1 | Lung | Primary cancer | 1,215 | Tumor/Malignant cell | 38.8% | 0.90 | 0.35 |